April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Intravitreal (IVT) injection exacerbates murine choroidal neovascularization (CNV) area by a MYD88 dependent mechanism
Author Affiliations & Notes
  • Elizabeth Fassbender
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA
  • Yubin Qiu
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA
  • Siyuan Shen
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA
  • Amber Woolfenden
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA
  • Andrea Delpero
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA
  • Yong Kim
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA
  • Bruce D Jaffee
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA
  • Stephen H Poor
    Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA
  • Footnotes
    Commercial Relationships Elizabeth Fassbender, Novartis (E); Yubin Qiu, Novartis (E); Siyuan Shen, Novartis (E); Amber Woolfenden, Novartis (E); Andrea Delpero, Novartis (E); Yong Kim, Novartis (E); Bruce Jaffee, Novartis (E); Stephen Poor, Novartis (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1194. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elizabeth Fassbender, Yubin Qiu, Siyuan Shen, Amber Woolfenden, Andrea Delpero, Yong Kim, Bruce D Jaffee, Stephen H Poor; Intravitreal (IVT) injection exacerbates murine choroidal neovascularization (CNV) area by a MYD88 dependent mechanism. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1194.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To compare the effect of route of administration of vehicle and the role of innate immunity in the mouse laser-induced CNV model.

Methods: We performed an analysis of CNV area in mice dosed vehicle by different routes of administration. CNV area in age and sex matched C57/BL6 mice were investigated after systemic or IVT administration of a toll receptor 3 activator, Polyinosinic:polycytidylic acid (poly I:C) or vehicle. A single 50µg dose or vehicle was administered i.v. at day -1 or day 2. A single IVT injection of 1.5 or 3.8µg poly I:C or vehicle was injected immediately after laser. CNV area was assessed in littermate age and sex matched MYD88 KO and toll receptor (TLR) 2 KO mice. Laser pulses were applied with an Iridex Oculight® GLx 532nm laser, 3 lesions/eye, 6 lesions/mouse, 9-15 mice/group yielding 54-90 data points per treatment group. On day 7 after laser, blood vessels were labeled with an i.v. injection of FITC-ConA and mice were euthanized. Eyes were enucleated and fixed in paraformaldehyde. Posterior ocular segments were dissected and mounted onto slides. CNV lesions were captured by fluorescent microscopy and CNV area was analyzed with Axiovision software. Analysis and exclusions were completed on masked data. Statistics were analyzed by an unpaired two tailed t test in Graph pad prism Vs6.

Results: CNV area was increased 42% in mice injected IVT with vehicle compared to mice receiving vehicle systemically (n=21 IVT vehicle studies, mean CNV area=17.0 ± 5.5 mm2 x 10-3; n=20 systemic vehicle studies, mean CNV area=12.8 ± 3.4 mm2 x 10-3, p=0.0066). CNV area in mice administered i.v. (n=2 studies) or IVT (n=3 studies) poly I:C was similar in size to CNV area in mice injected with saline (p>0.05). CNV area was similar in male MYD 88 KO mice and littermate controls (n=3 studies, p>0.05). Both male and female MYD88 KO mice injected with IVT saline had smaller CNV than control mice (male n=2 studies, mean % CNV inhibition in KO compared to WT=47%, p≤0.0038; females n=2 studies, mean % CNV inhibition in KO compared to WT=48%, p≤0.0042). CNV area was similar in size between TLR2 KO mice and controls injected IVT with saline (n=2 studies, p>0.05).

Conclusions: IVT injection exacerbates CNV area compared to non-injected mice. IVT injection increases CNV area through a MYD88-dependent mechanism, not through TLR2. Activation of TLR3 does not alter CNV area.

Keywords: 453 choroid: neovascularization • 609 neovascularization • 412 age-related macular degeneration  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×